Sabine Friedl

Title: The Innovative Contributions of Sabine Friedl

Introduction

Sabine Friedl is a notable inventor based in Bensheim, Germany. She has made significant contributions to the field of medical diagnostics, particularly in the quantification of vitamin D metabolites in blood samples. Her innovative approach has the potential to enhance the accuracy and efficiency of vitamin D testing.

Latest Patents

Friedl holds a patent for a method titled "Direct determination of vitamin D in serum or plasma." This method allows for the quantitation of vitamin D metabolites directly in blood plasma or serum without the need for prior purification. The process involves digesting serum proteins with a serine protease, such as proteinase K, followed by a sequence of steps to inhibit the proteinase K activity in competitive binding analysis. The advantages of this method include its high accuracy across the entire range of physiologically relevant values and its adaptability for fully automated analysis of serum and plasma samples. She has 1 patent to her name.

Career Highlights

Friedl is associated with Immundiagnostik AG, a company that specializes in the development of innovative diagnostic solutions. Her work has contributed to advancements in the field of immunodiagnostics, particularly in the accurate measurement of vital metabolites.

Collaborations

Friedl has collaborated with esteemed colleagues, including Franz Paul Armbruster and Heinz-Juergen Roth. Their combined expertise has furthered the development of diagnostic methods that are crucial for patient care.

Conclusion

Sabine Friedl's contributions to the field of medical diagnostics, particularly through her innovative patent on vitamin D quantification, highlight her role as a leading inventor. Her work not only enhances diagnostic accuracy but also paves the way for future advancements in the field.